Aa Aa Aa

Sucampo is a global pharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis.

Find out more.

News

  • May 15, 2013

    Sucampo to be Added to the NASDAQ Biotechnology Index

  • May 13, 2013

    Sucampo Pharmaceuticals to Host Update on AMITIZA® OIC Indication May 20th

  • May 7, 2013

    Sucampo Pharmaceuticals, Inc. Reports First Quarter 2013 Financial and Operating Results

  • April 30, 2013

    Sucampo Pharmaceuticals Announces First Quarter 2013 Results and Operating Highlights Teleconference and Webcast